Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1997 | 03-1997 | 12-1996 | 09-1996 | 06-1996 | |
| Gross Profit | N/A | 9,309 | 19,271 | 9,824 | 9,572 |
| Operating Expenses | 2,450 | 2,533 | 5,661 | 2,630 | 2,953 |
| Operating Income | -2,450 | -2,533 | -5,661 | -2,630 | -2,953 |
| Pre-tax Income | -2,450 | -2,533 | -5,661 | -2,630 | -2,953 |
| Net Income Continuous | -2,450 | -2,533 | -5,661 | -2,630 | -2,953 |
| Net Income | $-2,450 | $-2,533 | $-5,661 | $-2,630 | $-2,953 |
| EBITDA(a) | $-2,450 | $-749 | $-3,833 | $-988 | $-1,192 |